Table 1.
NAFLD, nonalcoholic fatty liver disease; BMI, body mass index; HOMA-IR, homeostatic model assessment-insulin resistance; AST, aspartate aminotransferase; ALT, alanine aminotransferase; LDL, low-density lipoprotein; HDL, high-density lipoprotein; CK-18, cytokeratin-18.